Published in Biochem Pharmacol on June 15, 1997
In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem (2006) 1.25
The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids. Biochem J (2005) 1.09
Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation. Biochem J (1998) 1.00
Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux. Antimicrob Agents Chemother (2006) 0.86
Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo. Cell Death Dis (2014) 0.77
Fexofenadine hydrochloride in the treatment of allergic disease: a review. J Asthma Allergy (2008) 0.75
Renal Drug Transporters and Drug Interactions. Clin Pharmacokinet (2017) 0.75
beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem (2001) 1.92
Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry (1996) 1.38
The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochemistry (1999) 1.33
Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. Biochemistry (2001) 1.24
A model for ganglioside behaviour in cell membranes. Biochim Biophys Acta (1978) 1.23
ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim Biophys Acta (1992) 1.20
The effects of lipids and detergents on ATPase-active P-glycoprotein. Biochim Biophys Acta (1993) 1.06
Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv Pharmacol (1990) 1.02
Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state. Eur J Biochem (2001) 1.01
Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides. Biochemistry (2000) 0.99
Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Biochim Biophys Acta (1992) 0.96
FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated. Biochemistry (2001) 0.93
The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids. Eur J Biochem (1998) 0.89
Glycosphingolipids in membrane architecture. J Supramol Struct (1977) 0.89
Release of the glycosylphosphatidylinositol-anchored enzyme ecto-5'-nucleotidase by phospholipase C: catalytic activation and modulation by the lipid bilayer. Biochem J (1998) 0.89
Glycolipids in model membranes. Spin label and freeze-etch studies. Biochim Biophys Acta (1976) 0.89
Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors. Immunology (1993) 0.89
Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter. Biochemistry (1997) 0.88
Gangliosides are potent immunosuppressors of IL-2-mediated T-cell proliferation in a low protein environment. Immunology (1995) 0.87
Strategies for the purification of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Protein Expr Purif (1991) 0.86
Studies on the interaction of human erythrocyte band 3 with membrane lipids using deuterium nuclear magnetic resonance and differential scanning calorimetry. Biochim Biophys Acta (1986) 0.84
Glycophorin as a receptor for Sendai virus. Biochemistry (1996) 0.84
MDR1 causes resistance to the antitumour drug miltefosine. Br J Cancer (2001) 0.83
Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study. Biochemistry (1998) 0.83
Interleukin-2 binds to gangliosides in micelles and lipid bilayers. Biochim Biophys Acta (1990) 0.83
Developmentally regulated changes in the glycoproteins of the equine embryonic capsule. J Reprod Fertil (1993) 0.82
Effect of micellar and bilayer gangliosides on proliferation of interleukin-2-dependent lymphocytes. Cell Immunol (1991) 0.82
Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles. Br J Cancer (1993) 0.82
Mucin-like glycoproteins in the equine embryonic capsule. Mol Reprod Dev (1993) 0.82
Glycophorin A interacts with interleukin-2 and inhibits interleukin-2-dependent T-lymphocyte proliferation. Cell Immunol (1992) 0.81
Solubilization, characterization, and detergent interactions of lymphocyte 5'-nucleotidase. Biochem Cell Biol (1989) 0.81
2H-NMR investigation of DMPC/glycophorin bilayers. Biochim Biophys Acta (1994) 0.80
Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation. Immunology (1995) 0.80
Glycophorin and the concanavalin A receptor of human erythrocytes: their receptor function in lipid bilayers. Proc Natl Acad Sci U S A (1977) 0.80
Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D. Biochim Biophys Acta (1994) 0.80
Immunosuppression by YAC-1 lymphoma: role of shed gangliosides. Cell Immunol (1996) 0.79
Reconstitution of lymphocyte 5'-nucleotidase in lipid bilayers: behaviour and interaction with concanavalin A. Can J Biochem Cell Biol (1985) 0.78
A ganglioside spin label: ganglioside head group interactions. Biochem Biophys Res Commun (1977) 0.77
Association of gangliosides with the lymphocyte plasma membrane studied using radiolabels and spin labels. Biochim Biophys Acta (1986) 0.77
Interaction of P-glycoprotein with defined phospholipid bilayers: a differential scanning calorimetric study. Biochemistry (1997) 0.77
Reconstitution of the glycosylphosphatidylinositol-anchored protein Thy-1: interaction with membrane phospholipids and galactosylceramide. Biochem Cell Biol (1999) 0.77
The concanavalin A receptor from human erythrocytes in lipid bilayer membranes. Interaction with concanavalin A and succinyl-concanavalin A. Biochim Biophys Acta (1983) 0.76
Isolation and incorporation into lipid vesicles of a concanavalin A receptor from human erythrocytes. Biochim Biophys Acta (1977) 0.76
Lipid-protein interactions of the human erythrocyte concanavalin A receptor in phospholipid bilayers. Biochim Biophys Acta (1984) 0.76
Direct modification of the glycocalyx of a cultured muscle cell line by incorporation of foreign gangliosides and an integral membrane glycoprotein. J Supramol Struct (1978) 0.75
Spin labelling of sialic acid and galactose residues on lymphocyte plasma membrane: effects of lectins on oligosaccharide dynamics. Mol Immunol (1985) 0.75
Functional reassembly of lymphocyte lentil lectin receptor glycoproteins into lipid bilayer vesicles. Biochim Biophys Acta (1983) 0.75
Effects of polychlorinated biphenyls on biological membranes: physical toxicity and molar volume relationships. Biochem Pharmacol (1980) 0.75
Effects of bovine serum albumin on the interaction of concanavalin A and succinyl-concanavalin A with phospholipid bilayers. Can J Biochem Cell Biol (1985) 0.75
Interaction of human erythrocyte Band 3 with Ricinus communis agglutinin and other lectins. Biochim Biophys Acta (1985) 0.75
Inhibition of mouse lymphocyte 5'-nucleotidase by cannabinoids: a physical toxicity effect. Biochem Pharmacol (1984) 0.75
Biochemical changes in the equine capsule following prostaglandin-induced pregnancy failure. Mol Reprod Dev (1997) 0.75